Please assess the completion status of the following clinical trial:

Trial Title: Laser Treatment for Fresh Surgical Scars and Mature Scars

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Fitzpatrick Skin Type I-VI and either a fresh surgical scar (with sutures still present \[or dissolving sutures within 7 days of surgery for facial scars or within 14 days of surgery for scars on the trunk or extremities) of at least 2cm in length or an erythematous and/or hypertrophic scar of at least 2cm in length and of greater than or equal to 18 months in duration~* Scar is easily divisible into two equal segments for the purpose of the study, or is bilateral in nature (e.g., inframammary)~Exclusion Criteria:~* Pregnant, lactating, or is planning to become pregnant~* history of cutaneous photosensitization, porphyria, hypersensitivity to porphyrins or photodermatosis~* any skin pathology/condition that could interfere with evaluation or requires the use of interfering topical systemic therapy~* coagulation disorder or currently using anti-coagulation medication (including but not limited to heavy aspirin therapy)~* any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in the study~* currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within 30 days~* unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function~* unreliable for the study, including subjects who engage in excessive alcohol intake or drug abuse, or subjects who are unable to return for scheduled follow-up visits~* Isotretinoin therapy within 6 months~* need to be exposed to artificial tanning devices or excessive sunlight during the trial~* prior treatment with parenteral gold therapy~* does not agree to refrain from other laser treatment, (micro)dermabrasion or topical scar treatment creams for the duration of the study~* Diabetes Type 1 or 2~* Lupus, scleroderma or similar immune system disorder~* underlying silicone or other non-absorbable filler in the area of the scar~* phenol chemical peel or dermabrasion to the area of the scar within 3 months~* Fitzpatrick Skin Type IV, V or VI with a known sensitivity to hydroquinone or is unwilling or unable to comply with physician/manufacturer instructions for the use of this ingredient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Fresh surgical scars (Type: EXPERIMENTAL): Treatment of scars
- Mature scars (Type: EXPERIMENTAL): Treatment of scars

Based on this trial design, predict the completion outcome and termination type (if applicable).